Notícias Eulerpool Eisai Co

Eisai Co Eulerpool-AFX

Eisai Co Notícias de ações

Eisai Co é observado por muitos jornalistas e investidores em todo o mundo. As notícias mais recentes de Eisai Co nós reunimos aqui.

• 17 de junho ·

  SeekingAlpha
  Eli Lilly And Alzheimer's Disease: The Paucity Of Progress
• 17 de junho ·

  Yahoo
  Two Is Better Than One in the Alzheimer’s Market
• 2 de junho ·

  SeekingAlpha
  Week In Review: MediLink And BioNTech Form $1.8B ADC Partnership
• 16 de maio ·

  SeekingAlpha
  Eisai Co Ltd. (ESALF) Q4 2024 Earnings Call Transcript
• 15 de maio ·

  Yahoo
  Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease Under the Fast Track Status
• 30 de abril ·

  SeekingAlpha
  Biogen: Don't Overthink This One
• 24 de abril ·

  Yahoo
  Alzheimer’s Drug Leqembi Sees Sales Pickup, Boosting Biogen Stock
• 22 de abril ·

  SeekingAlpha
  Eli Lilly And The Alzheimer's Dilemma (Rating Upgrade)
• 1 de abril ·

  Yahoo
  Eisai Completes Submission of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease to the U.S. FDA
• 17 de março ·

  SeekingAlpha
  Eisai: All About Lenvima And Leqembi